Treatments
545 articles
Aiming to Improve Immunotherapy for Pancreatic Cancer
Dr. Deirdre Cohen discusses clinical trials that aim to improve the effectiveness of immunotherapy for pancreatic cancer.
Modifying the Tumor Microenvironment to Make Treatment More Effective
Researchers are testing a new drug that better-allows chemotherapy to penetrate the tumor microenvironment of pancreatic cancer.
Testing a PARP Inhibitor for Metastatic Pancreatic Cancer Patients with DNA Repair Mutations
Researchers are testing a PARP inhibitor that is effective for cancers in pancreatic cancer patients with DNA repair mutations.
Finding the Best Dose of Radiation and an Experimental Drug
A clinical trial looks for the best dose of an experimental drug to combat the mouth sores that are a side effect of stereotactic body radiation therapy.
Testing the Effectiveness of Radiation and Standard Treatment
A clinical trial compares FOLFIRINOX plus stereotactic body radiation therapy (SBRT) with just FOLFIRINOX for pancreatic cancer that has spread locally.
A Look Back at Research in 2024
Research in 2024 focused on personally tailored treatments, countering the most difficult effects of pancreatic cancer, and clinical trials.
RASolute 302 Trial for KRAS and Other RAS Mutations Recruiting at Multiple Sites
Dr. Hani Babiker is optimistic about the new drug to treat patients with KRAS mutations, now in a phase III trial.
Testing the Addition of a New Drug to Radiation Therapy for Localized Pancreatic Cancer
In combination with radiation treatment, researchers are testing a new drug that causes DNA damage to make that treatment more effective.
Making Surgery An Option for More Pancreatic Cancer Patients
Dr. John Chabot explains that more pancreatic cancer patients may qualify for surgery if they consult an experience pancreatic surgical team.
Slowing the Growth of One Type of Advanced Neuroendocrine Tumor
Dr. Kelsey Klute explains the advantages of the radiopharmaceutical lutetium Lu 177 dotatate treatment for certain neuroendocrine tumors.
Understanding How Super-Enhancers Rev Up Pancreatic Cancer Growth
Researcher Ronald Evans, Ph.D., and his team at the Salk Institute are focusing on how super-enhancers stimulate pancreatic cancer growth.
Is Pancreatic Cancer Different in Black Patients?
Pancreatic cancer occurs at a higher rate in Black patients. Dr. Howard Crawford leads a study looking at the cancer biology for differences.
Large Phase III Global Trial Targets Cancer Metabolism
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.
Cachexia Research Gaining Momentum
Why do pancreatic cancer patients lose weight even if they are eating well? Dr. Teresa Zimmers explains the syndrome called cachexia.
An Interview with Dr. Tyler Jacks
Dr. Tyler Jacks is one of the leading pancreatic cancer researchers. Read what he has to say about KRAS, organoids, and running a lab in a pandemic.